November 24, 2014December 1, 2014

Experimental Pediatric Ulcerative Colitis Drug Picks Up Orphan Drug Status

News, Ulcerative colitis

AvaxiaBiologics,Inc. recently announced that the US Food and Drug Administration (FDA) granted their lead experimental drug AVX-470 Orphan Drug Designation for the treatment of pediatric ulcerative colitis. The news comes after the company previously announced the results ... Read more

October 17, 2014October 17, 2014

New Ulcerative Colitis Drug Study Results To Be Presented By Avaxia Biologics

News, Ulcerative colitis

New research and development news for ulcerative colitis (UC) indicates that a promising, new front-line therapy for the disease that can be taken in pill form may be making its ... Read more